Datasets:

Haxirus

/

Fine-Tuning_Dataset

like 0

Does Adalimumab and Interferon alfa-2a interact?

Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Interferon alfa-2a is combined with Adalimumab, and the severity of the interaction is major.

Does Adalimumab and Interferon alfa-2b interact?

Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Adalimumab is combined with Interferon alfa-2b, and the severity of the interaction is major.

Does Adalimumab and Interferon alfa-n3 interact?

Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Adalimumab, and the severity of the interaction is major.

Does Adalimumab and Interferon beta-1b interact?

Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Adalimumab is combined with Interferon beta-1b, and the severity of the interaction is major.

Does Adalimumab and Interferon gamma-1b interact?

Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Adalimumab, and the severity of the interaction is major.

Does Adalimumab and Ipilimumab interact?

Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Adalimumab is combined with Ipilimumab, and the severity of the interaction is minor.

Does Adalimumab and Iptacopan interact?

The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2D6 substrates. In short, The metabolism of Iptacopan can be increased when combined with Adalimumab, and the severity of the interaction is moderate.

Does Adalimumab and Irbesartan interact?

The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2C9 substrates. In short, The metabolism of Irbesartan can be increased when combined with Adalimumab, and the severity of the interaction is moderate.

Does Adalimumab and Irinotecan interact?

The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP3A4 substrates with a narrow therapeutic index. In short, The metabolism of Irinotecan can be increased when combined with Adalimumab, and the severity of the interaction is major.

Does Adalimumab and Isatuximab interact?

Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Adalimumab is combined with Isatuximab, and the severity of the interaction is minor.

Does Adalimumab and Isavuconazole interact?

The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP3A4 substrates. In short, The metabolism of Isavuconazole can be increased when combined with Adalimumab, and the severity of the interaction is moderate.

Does Adalimumab and Isavuconazonium interact?

The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP3A5 substrates. In short, The metabolism of Isavuconazonium can be increased when combined with Adalimumab, and the severity of the interaction is moderate.

Does Adalimumab and Isoflurane interact?

The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2B6 substrates. In short, The metabolism of Isoflurane can be increased when combined with Adalimumab, and the severity of the interaction is moderate.

Does Adalimumab and Istradefylline interact?

The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP1A2 substrates. In short, The metabolism of Istradefylline can be increased when combined with Adalimumab, and the severity of the interaction is moderate.

Does Adalimumab and Ivacaftor interact?

The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP3A5 substrates. In short, The metabolism of Ivacaftor can be increased when combined with Adalimumab, and the severity of the interaction is moderate.

Does Adalimumab and Ivosidenib interact?

The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP3A4 substrates with a narrow therapeutic index. In short, The metabolism of Ivosidenib can be increased when combined with Adalimumab, and the severity of the interaction is major.

Does Adalimumab and Ixabepilone interact?

The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP3A4 substrates with a narrow therapeutic index. In short, The metabolism of Ixabepilone can be increased when combined with Adalimumab, and the severity of the interaction is major.

Does Adalimumab and Ixazomib interact?

The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP3A4 substrates with a narrow therapeutic index. In short, The metabolism of Ixazomib can be increased when combined with Adalimumab, and the severity of the interaction is major.

Does Adalimumab and Ixekizumab interact?

Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Adalimumab is combined with Ixekizumab, and the severity of the interaction is major.

Does Adalimumab and Janssen COVID-19 Vaccine interact?

Vaccine efficacy may be reduced when immunosuppressant medications are coadministered. Vaccines are designed to elicit an immune response, and this response may be inhibited by immunosuppressants. The administration of live vaccines can also provide a risk as the infection process can be developed due to the immunosuppressive agent. In short, The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Adalimumab, and the severity of the interaction is moderate.

Does Adalimumab and Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) interact?

Vaccine efficacy may be reduced when immunosuppressant medications are coadministered. Vaccines are designed to elicit an immune response, and this response may be inhibited by immunosuppressants. The administration of live vaccines can also provide a risk as the infection process can be developed due to the immunosuppressive agent. In short, The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Adalimumab, and the severity of the interaction is moderate.

Does Adalimumab and Ketamine interact?

The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2B6 substrates. In short, The metabolism of Ketamine can be increased when combined with Adalimumab, and the severity of the interaction is moderate.

Does Adalimumab and Ketorolac interact?

The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2C9 substrates. In short, The metabolism of Ketorolac can be increased when combined with Adalimumab, and the severity of the interaction is moderate.

Does Adalimumab and Labetalol interact?

The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2C19 substrates. In short, The metabolism of Labetalol can be increased when combined with Adalimumab, and the severity of the interaction is moderate.

Does Adalimumab and Lacosamide interact?

The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2C19 substrates. In short, The metabolism of Lacosamide can be increased when combined with Adalimumab, and the severity of the interaction is moderate.

Does Adalimumab and Lanadelumab interact?

Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Adalimumab is combined with Lanadelumab, and the severity of the interaction is minor.

Does Adalimumab and Lansoprazole interact?

The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2C19 substrates. In short, The metabolism of Lansoprazole can be increased when combined with Adalimumab, and the severity of the interaction is moderate.

Does Adalimumab and Lapatinib interact?

The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2C19 substrates. In short, The metabolism of Lapatinib can be increased when combined with Adalimumab, and the severity of the interaction is moderate.

Does Adalimumab and Lebrikizumab interact?

Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Adalimumab is combined with Lebrikizumab, and the severity of the interaction is minor.

Does Adalimumab and Lecanemab interact?

Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Adalimumab is combined with Lecanemab, and the severity of the interaction is minor.

Does Adalimumab and Lefamulin interact?

The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP3A4 substrates. In short, The metabolism of Lefamulin can be increased when combined with Adalimumab, and the severity of the interaction is moderate.

Does Adalimumab and Leflunomide interact?

The immunosuppressive effects of leflunomide may be augmented by the concurrent administration of immunosuppressive agents, leading to an increased risk of serious infection and/or lymphoproliferative disorders resulting from bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Adalimumab is combined with Leflunomide, and the severity of the interaction is moderate.

Does Adalimumab and Lemborexant interact?

The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP3A5 substrates. In short, The metabolism of Lemborexant can be increased when combined with Adalimumab, and the severity of the interaction is moderate.

Does Adalimumab and Lenalidomide interact?

Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Adalimumab is combined with Lenalidomide, and the severity of the interaction is major.

Does Adalimumab and Lercanidipine interact?

The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP3A5 substrates. In short, The metabolism of Lercanidipine can be increased when combined with Adalimumab, and the severity of the interaction is moderate.

Does Adalimumab and Letrozole interact?

The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2A6 substrates. In short, The metabolism of Letrozole can be increased when combined with Adalimumab, and the severity of the interaction is moderate.

Does Adalimumab and Levamlodipine interact?

The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP3A5 substrates. In short, The metabolism of Levamlodipine can be increased when combined with Adalimumab, and the severity of the interaction is moderate.

Does Adalimumab and Levobupivacaine interact?

The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP1A2 substrates. In short, The metabolism of Levobupivacaine can be increased when combined with Adalimumab, and the severity of the interaction is moderate.

Does Adalimumab and Levonorgestrel interact?

The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP3A5 substrates. In short, The metabolism of Levonorgestrel can be increased when combined with Adalimumab, and the severity of the interaction is moderate.

Does Adalimumab and Lidocaine interact?

The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP1A2 substrates. In short, The metabolism of Lidocaine can be increased when combined with Adalimumab, and the severity of the interaction is moderate.

Does Adalimumab and Linagliptin interact?

The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP3A4 substrates. In short, The metabolism of Linagliptin can be increased when combined with Adalimumab, and the severity of the interaction is moderate.

Does Adalimumab and Linezolid interact?

Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Adalimumab is combined with Linezolid, and the severity of the interaction is major.

Does Adalimumab and Lofexidine interact?

The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP1A2 substrates. In short, The metabolism of Lofexidine can be increased when combined with Adalimumab, and the severity of the interaction is moderate.

Does Adalimumab and Lomefloxacin interact?

The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP1A2 substrates. In short, The metabolism of Lomefloxacin can be increased when combined with Adalimumab, and the severity of the interaction is moderate.

Does Adalimumab and Lomitapide interact?

The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP3A4 substrates with a narrow therapeutic index. In short, The metabolism of Lomitapide can be increased when combined with Adalimumab, and the severity of the interaction is major.

Does Adalimumab and Lomustine interact?

Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Adalimumab is combined with Lomustine, and the severity of the interaction is major.

Does Adalimumab and Lonafarnib interact?

The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2C9 substrates. In short, The metabolism of Lonafarnib can be increased when combined with Adalimumab, and the severity of the interaction is moderate.

Does Adalimumab and Loncastuximab tesirine interact?

Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Adalimumab is combined with Loncastuximab tesirine, and the severity of the interaction is minor.

Does Adalimumab and Loperamide interact?

The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2C8 substrates. In short, The metabolism of Loperamide can be increased when combined with Adalimumab, and the severity of the interaction is moderate.

Does Adalimumab and Lorlatinib interact?

The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP3A5 substrates. In short, The metabolism of Lorlatinib can be increased when combined with Adalimumab, and the severity of the interaction is moderate.

Does Adalimumab and Lornoxicam interact?

The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2C9 substrates. In short, The metabolism of Lornoxicam can be increased when combined with Adalimumab, and the severity of the interaction is moderate.

Does Adalimumab and Losartan interact?

The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2C9 substrates. In short, The metabolism of Losartan can be increased when combined with Adalimumab, and the severity of the interaction is moderate.

Does Adalimumab and Lovastatin interact?

The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP3A5 substrates. In short, The metabolism of Lovastatin can be increased when combined with Adalimumab, and the severity of the interaction is moderate.

Does Adalimumab and Lynestrenol interact?

The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2C19 substrates. In short, The metabolism of Lynestrenol can be increased when combined with Adalimumab, and the severity of the interaction is moderate.

Does Adalimumab and Magnesium interact?

Co-administration of magnesium with certain immunosuppressive agents (cyclosporin, ritodrine) may lead to a decrease in serum concentrations of magnesium. In short, The serum concentration of Magnesium can be decreased when it is combined with Adalimumab, and the severity of the interaction is moderate.

Does Adalimumab and Maprotiline interact?

The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP1A2 substrates. In short, The metabolism of Maprotiline can be increased when combined with Adalimumab, and the severity of the interaction is moderate.

Does Adalimumab and Margetuximab interact?

Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Adalimumab is combined with Margetuximab, and the severity of the interaction is minor.

Does Adalimumab and Mavacamten interact?

The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2C19 substrates. In short, The metabolism of Mavacamten can be increased when combined with Adalimumab, and the severity of the interaction is moderate.

Does Adalimumab and Measles virus vaccine live attenuated interact?

Vaccine efficacy may be reduced when immunosuppressant medications are coadministered. Vaccines are designed to elicit an immune response, and this response may be inhibited by immunosuppressants. The administration of live vaccines can also provide a risk as the infection process can be developed due to the immunosuppressive agent. In short, The therapeutic efficacy of Measles virus vaccine live attenuated can be decreased when used in combination with Adalimumab, and the severity of the interaction is moderate.

Does Adalimumab and Mechlorethamine interact?

Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Adalimumab is combined with Mechlorethamine, and the severity of the interaction is major.

Does Adalimumab and Meclizine interact?

The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2D6 substrates. In short, The metabolism of Meclizine can be increased when combined with Adalimumab, and the severity of the interaction is moderate.

Does Adalimumab and Mefenamic acid interact?

The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP1A2 substrates. In short, The metabolism of Mefenamic acid can be increased when combined with Adalimumab, and the severity of the interaction is moderate.

Does Adalimumab and Melatonin interact?

The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP1A2 substrates. In short, The metabolism of Melatonin can be increased when combined with Adalimumab, and the severity of the interaction is moderate.

Does Adalimumab and Meloxicam interact?

The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2C9 substrates. In short, The metabolism of Meloxicam can be increased when combined with Adalimumab, and the severity of the interaction is moderate.

Does Adalimumab and Melphalan interact?

Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Adalimumab is combined with Melphalan, and the severity of the interaction is major.

Does Adalimumab and Meperidine interact?

The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2B6 substrates. In short, The metabolism of Meperidine can be increased when combined with Adalimumab, and the severity of the interaction is moderate.

Does Adalimumab and Mepolizumab interact?

Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Adalimumab is combined with Mepolizumab, and the severity of the interaction is major.

Does Adalimumab and Mercaptopurine interact?

According to the FDA label for adalimumab 5 the formation of CYP450 enzymes may be suppressed by increased levels of cytokines (for example, TNFα, IL-6) during chronic inflammation. It is possible for a drug that antagonizes cytokine activity, such as adalimumab, to influence the formation of CYP450 enzymes, increasing the metabolism of xanthine derivatives. These drugs are primarily metabolized by CYP450 enzymes. In short, The serum concentration of Mercaptopurine can be decreased when it is combined with Adalimumab, and the severity of the interaction is moderate.

Does Adalimumab and Metamfetamine interact?

The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2D6 substrates. In short, The metabolism of Metamfetamine can be increased when combined with Adalimumab, and the severity of the interaction is moderate.

Does Adalimumab and Methadone interact?

The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2B6 substrates. In short, The metabolism of Methadone can be increased when combined with Adalimumab, and the severity of the interaction is moderate.

Does Adalimumab and Methimazole interact?

Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Adalimumab is combined with Methimazole, and the severity of the interaction is major.

Does Adalimumab and Methotrexate interact?

Methotrexate reduced adalimumab apparent clearance after single and multiple dosing by 29% and 44% respectively, in patients with rheumatoid arthritis. In short, Methotrexate may decrease the excretion rate of Adalimumab which could result in a higher serum level, and the severity of the interaction is minor.

Does Adalimumab and Methotrimeprazine interact?

The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2D6 substrates. In short, The metabolism of Methotrimeprazine can be increased when combined with Adalimumab, and the severity of the interaction is moderate.

Does Adalimumab and Methoxyflurane interact?

The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2A6 substrates. In short, The metabolism of Methoxyflurane can be increased when combined with Adalimumab, and the severity of the interaction is moderate.

Does Adalimumab and Methsuximide interact?

The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2C19 substrates. In short, The metabolism of Methsuximide can be increased when combined with Adalimumab, and the severity of the interaction is moderate.

Does Adalimumab and Methylene blue interact?

The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP1A2 substrates. In short, The metabolism of Methylene blue can be increased when combined with Adalimumab, and the severity of the interaction is moderate.

Does Adalimumab and Methylprednisolone interact?

Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Adalimumab is combined with Methylprednisolone, and the severity of the interaction is major.

Does Adalimumab and Methyltestosterone interact?

The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2B6 substrates. In short, The metabolism of Methyltestosterone can be increased when combined with Adalimumab, and the severity of the interaction is moderate.

Does Adalimumab and Metoclopramide interact?

The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP1A2 substrates. In short, The metabolism of Metoclopramide can be increased when combined with Adalimumab, and the severity of the interaction is moderate.

Does Adalimumab and Metoprolol interact?

The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2D6 substrates. In short, The metabolism of Metoprolol can be increased when combined with Adalimumab, and the severity of the interaction is moderate.

Does Adalimumab and Metronidazole interact?

The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2A6 substrates. In short, The metabolism of Metronidazole can be increased when combined with Adalimumab, and the severity of the interaction is moderate.

Does Adalimumab and Mexiletine interact?

The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP1A2 substrates. In short, The metabolism of Mexiletine can be increased when combined with Adalimumab, and the severity of the interaction is moderate.

Does Adalimumab and Mianserin interact?

The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP1A2 substrates. In short, The metabolism of Mianserin can be increased when combined with Adalimumab, and the severity of the interaction is moderate.

Does Adalimumab and Midazolam interact?

The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP3A5 substrates. In short, The metabolism of Midazolam can be increased when combined with Adalimumab, and the severity of the interaction is moderate.

Does Adalimumab and Midostaurin interact?

The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP3A4 substrates with a narrow therapeutic index. In short, The metabolism of Midostaurin can be increased when combined with Adalimumab, and the severity of the interaction is major.

Does Adalimumab and Mifepristone interact?

The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP3A5 substrates. In short, The metabolism of Mifepristone can be increased when combined with Adalimumab, and the severity of the interaction is moderate.

Does Adalimumab and Mirabegron interact?

The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2D6 substrates. In short, The metabolism of Mirabegron can be increased when combined with Adalimumab, and the severity of the interaction is moderate.

Does Adalimumab and Mirtazapine interact?

The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP1A2 substrates. In short, The metabolism of Mirtazapine can be increased when combined with Adalimumab, and the severity of the interaction is moderate.

Does Adalimumab and Mirvetuximab soravtansine interact?

Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Adalimumab is combined with Mirvetuximab Soravtansine, and the severity of the interaction is minor.

Does Adalimumab and Mitomycin interact?

Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Adalimumab is combined with Mitomycin, and the severity of the interaction is major.

Does Adalimumab and Mitoxantrone interact?

Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Adalimumab is combined with Mitoxantrone, and the severity of the interaction is major.

Does Adalimumab and Mobocertinib interact?

The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP3A5 substrates. In short, The metabolism of Mobocertinib can be increased when combined with Adalimumab, and the severity of the interaction is moderate.

Does Adalimumab and Moclobemide interact?

The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2C19 substrates. In short, The metabolism of Moclobemide can be increased when combined with Adalimumab, and the severity of the interaction is moderate.

Does Adalimumab and Modafinil interact?

The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP3A5 substrates. In short, The metabolism of Modafinil can be increased when combined with Adalimumab, and the severity of the interaction is moderate.

Does Adalimumab and Moderna COVID-19 Vaccine interact?

Vaccine efficacy may be reduced when immunosuppressant medications are coadministered. Vaccines are designed to elicit an immune response, and this response may be inhibited by immunosuppressants. The administration of live vaccines can also provide a risk as the infection process can be developed due to the immunosuppressive agent. In short, The therapeutic efficacy of Moderna COVID-19 Vaccine can be decreased when used in combination with Adalimumab, and the severity of the interaction is moderate.

Does Adalimumab and Modified vaccinia ankara interact?

Vaccine efficacy may be reduced when immunosuppressant medications are coadministered. Vaccines are designed to elicit an immune response, and this response may be inhibited by immunosuppressants. The administration of live vaccines can also provide a risk as the infection process can be developed due to the immunosuppressive agent. In short, The therapeutic efficacy of Modified vaccinia ankara can be decreased when used in combination with Adalimumab, and the severity of the interaction is moderate.

Does Adalimumab and Mogamulizumab interact?

Biologic therapies carry a risk of immunogenicity which can produce a wide array of adverse effects the most serious of which include anaphylaxis and serum sickness-type reactions . Use of multiple immunoglobulin-based therapies may increase the risk of these immunological complications. A few studies suggest the use of multiple immunoglobulin agents is relatively safe and may be more effective than monotherapy for certain conditions . In short, The risk or severity of adverse effects can be increased when Adalimumab is combined with Mogamulizumab, and the severity of the interaction is minor.

Does Adalimumab and Mometasone furoate interact?

Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Adalimumab is combined with Mometasone furoate, and the severity of the interaction is major.

Does Adalimumab and Monomethyl fumarate interact?

Immunosuppressive agents may exert an additive effect on other immunosuppressive agents, leading to a greater risk of infection due to bone marrow suppression. In short, The risk or severity of adverse effects can be increased when Adalimumab is combined with Monomethyl fumarate, and the severity of the interaction is major.

Does Adalimumab and Montelukast interact?

The formation of CYP450 enzymes is inhibited by the presence of increased levels of cytokines during chronic inflammation. Agents that reduce cytokine levels can normalize CYP450 formation and increase the metabolism of drugs. This interaction may significantly alter the therapeutic efficacy of CYP2A6 substrates. In short, The metabolism of Montelukast can be increased when combined with Adalimumab, and the severity of the interaction is moderate.